Cargando…
Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
Cancer stem cells (CSCs) are one of the reasons for the relapse of cancer cells and metastasis. They have drug resistance against most chemotherapeutic agents. CSCs are also responsible for tumor cell heterogeneity and cause minimal residual disease. In order to achieve complete regression of tumors...
Autores principales: | Badrinath, Narayanasamy, Yoo, So Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468501/ https://www.ncbi.nlm.nih.gov/pubmed/30841635 http://dx.doi.org/10.3390/cancers11030310 |
Ejemplares similares
-
Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
por: Yoo, So Young, et al.
Publicado: (2017) -
Viruses as nanomedicine for cancer
por: Badrinath, Narayanasamy, et al.
Publicado: (2016) -
Recent Advances in Cancer Immunotherapy Delivery Modalities
por: Muthukutty, Palaniyandi, et al.
Publicado: (2023) -
Recent advances in cancer immunotherapy
por: Sun, Qiang, et al.
Publicado: (2021) -
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)